Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Isotope & RadiationHKSE:01763 -1.88%92 Days Payable is 67.67 as of Dec. 2025, which is 6% above its 10-year median of 63.82. GuruFocus rates HKSE:01763 with a GF Score™ of 92/100 and a GF Value™ of HK$15.74 (Fairly Valued). The stock has 5 warning signs investors should review. Among 793 Medical Devices & Instruments companies, China Isotope & Radiation ranks better than 57.38% on this metric.
The historical rank and industry rank for China Isotope & Radiation's Days Payable or its related term are showing as below:
HKSE:01763'
s Days Payable Range Over the Past 10 Years
Min: 39.89 Med: 63.82 Max: 81.28
Current: 81.28
During the past 11 years, China Isotope & Radiation's highest Days Payable was 81.28. The lowest was 39.89. And the median was 63.82.
HKSE:01763's Days Payable is ranked better than 57.38% of 793
companies
in the Medical Devices & Instruments industry
Industry Median: 68.47
vs HKSE:01763: 81.28
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01763 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, China Isotope & Radiation's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Isotope & Radiation Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's Days Payable distribution charts can be found below:
* The bar in red indicates where China Isotope & Radiation's Days Payable falls into.
China Isotope & Radiation Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
China Isotope & Radiation's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Isotope & Radiation (HKSE:01763) has a Days Payable of 67.67 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on China Isotope & Radiation and its competitors. This is near median its historical median of 63.82. Over the past decade, China Isotope & Radiation's Days Payable has ranged from 39.89 to 81.28. According to the industry distribution chart, China Isotope & Radiation ranks #338 out of 793 companies in the Medical Devices & Instruments industry, placing it in the top 42.6%.
Is China Isotope & Radiation's Days Payable too high?
China Isotope & Radiation's current Days Payable of 67.67 is near median its 10-year median of 63.82. Over the past 10 years, this metric has ranged from a low of 39.89 to a high of 81.28. The Medical Devices & Instruments industry median Days Payable is 68.47. China Isotope & Radiation's value of 67.67 is 1.2% below this industry median. Based on the distribution chart, China Isotope & Radiation ranks #338 out of 793 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, China Isotope & Radiation has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does China Isotope & Radiation's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, China Isotope & Radiation ranks #338 out of 793 companies for Days Payable. This puts China Isotope & Radiation in the upper half of its industry. The industry median Days Payable is 68.47. China Isotope & Radiation's value of 67.67 is 1.2% below this benchmark. Historically, China Isotope & Radiation's own Days Payable has ranged from 39.89 to 81.28 over the past decade. While the company's 10-year median is 63.82 vs. the industry median of 68.47, China Isotope & Radiation has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.47, based on 793 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Isotope & Radiation's current Days Payable of 67.67 is 1.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on China Isotope & Radiation and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Isotope & Radiation's current Days Payable is 67.67, which is near median its own 10-year median of 63.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Isotope & Radiation stock overvalued right now?
Based on GuruFocus' analysis, China Isotope & Radiation (HKSE:01763) is currently considered Fairly Valued. The stock's GF Value™ is HK$15.74, compared to a current price of HK$16.70 — trading 6.1% above its estimated fair value. The current Days Payable is 67.67, which is near median its 10-year median of 63.82 and 1.2% below the Medical Devices & Instruments industry median of 68.47. China Isotope & Radiation's overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For China Isotope & Radiation (HKSE:01763), the current Days Payable is 67.67 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Isotope & Radiation (HKSE:01763) Overvalued in 2026?
Based on GuruFocus' analysis, China Isotope & Radiation stock appears to be overvalued.
The current stock price of HK$16.70 is trading 6.1% above its estimated GF Value™ of HK$15.74.
GuruFocus considers China Isotope & Radiation to be Fairly Valued.
Key valuation signals for HKSE:01763:
Days Payable: 67.67 (near median its 10-year median of 63.82)
GF Value™: HK$15.74 vs. price of HK$16.70 (6.1% above fair value)
Industry Position: 1.2% below the Medical Devices & Instruments median (#338 of 793)
No single metric tells the full story. See the HKSE:01763 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: (1) nuclear medicine; (2) radioactive source products; (3) irradiation; (4) nuclear medical equipment and related services; and (5) other businesses. Nuclear medicines: manufacturing and sale of a range of imaging diagnostic and therapeutic radio pharmaceuticals imaging, UBT diagnostic kits and test analysers and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The company's operations are carried out and a majority of its customers are located in the PRC.
92GF Score
Get the complete analysis for HKSE:01763
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01763 has been successfully added to your 
